Is vulvovaginal candidiasis an AIDS-related illness?

Clinical Infectious Diseases

Volumn 22, Issue SUPPL. 2, 1996, Pages

  White, Mary H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; DISEASE ASSOCIATION; ESOPHAGUS DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; INFECTION RISK; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; VAGINA CANDIDIASIS;

EID: 0030054520     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.supplement_2.s124     Document Type: Conference Paper

References (29)

1. Schoenbaum EE, Webber MP. The underrecognition of HIV infection in women in an inner-city emergency room. Am J Public Health 1993;83:363-8.
2. Lemp GF, Hirozawa AM, Cohen JB, Derish PA, McKinney KC, Hernandez SR. Survival for women and men with AIDS. J Infect Dis 1992;166:74-9.
3. DeHart DJ. HIV testing in women with vaginal candidiasis. Am J Med 1991;90:536.
4. Imam N, Carpenter CCJ, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990;89:142-6.
5. Carpenter CCJ, Mayer KH, Fisher A, Desai MB, Durand L. Natural history of acquired immunodeficiency syndrome in women in Rhode Island. Am J Med 1989;86:771-5.
6. New York City Department of Health AIDS Surveillance. The AIDS epidemic in New York City, 1981-1984. Am J Epidemiol 1986;123:1013-25.
7. Morlat P, Parneix P, Douard D, et al. Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. AIDS 1992;6:1187-93.
8. Phillips AN, Antunes F, Stergious G, et al. A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS 1994;8:831-5.
9. Vlahov D, Munoz A, Solomon L, et al. Comparison of clinical manifestations of HIV infection between male and female injecting drug users. AIDS 1994;8:819-23.
10. Monif GRG. Classification and pathogenesis of vulvovaginal candidiasis. Am J Obstet Gynecol 1985;152:935-9.
11. Odds FC. Ecology of Candida and epidemiology of candidosis. In: Odds FC, ed. Candida and candidosis: a review and bibliography. 2nd ed. London: Balliere Tindall, 1988:68-92.
12. Fleury FJ. Adult vaginitis. Clin Obstet Gynecol 1981;24:407-38.
13. Adler MW, Belsey EM, Rogers JS. Sexually transmitted diseases in a defined population of women. Br Med J 1981;283:29-32.
14. Adler M, Belsey E. The G.P. and the specialist: gynaecology. Br Med J 1983;286:890.
15. Berg AO, Heidrich FE, Fihn SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice. JAMA 1984;251: 620-5.
16. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 1992;14(suppl 1):S148-53.
17. Forssman L, Milsom J. Treatment of recurrent vaginal candidiasis. Am J Obstet Gynecol 1985;152:959-61.
18. Milne JD, Warnock DW. Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidiasis. Br J Vener Dis 1979;55:362-6.
19. Rodin P, Kolator B. Carriage of yeasts on the penis. Br Med J 1976;1:1123-4.
20. Sobel JD. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol 1985;65:435-40.
21. Vazquez JA, Sobel JD, Demitriou R, Vaishampayan J, Lynch M, Zervos MJ. Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis. J Infect Dis 1994;170:1566-9.
22. Rhoads JL, Wright C, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987;257:3105-7.
23. Carpenter CCJ, Mayer KH, Stein MD, Leibman BD, Fisher A, Fiore TC. Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature. Medicine (Baltimore) 1991;70:307-25.
24. Klein RS, Harris CS, Small CB, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-8.
25. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbid Mortal Wkly Rep 1992;41(RR-17):1-19.
26. Burns D, Tuomala R, Regan J, et al. Positive vaginal cultures for C. albicans correlate with CD4+ level among pregnant and postpartum HIV-1-infected women [abstract no 1676]. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1993:425.
27. Clark R, Brandon W, Blakley S, Rice J. Clinical manifestations in HIV+ women [abstract no 1329]. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1993:363.
28. Ellerbrock T, Wright T, Rice R, Chiasson MA. Genital tract infections in HIV-infected women [abstract no FC1-180]. In: Program and abstracts of the 1st HIV Infection in Women Conference (Washington, DC). Richmond, VA: Philadelphia Sciences Group, 1995.
29. Schuman P, Sobel JD, Mayer K, et al. Candida colonization in women at risk for HIV infection [abstract no FC1-176]. In: Program and abstracts of the 1st HIV Infection in Women Conference (Washington, DC). Richmond, VA: Philadelphia Sciences Group, 1995.